Superbugs could set medicine back to the 19th century, before the discovery of penicillin, when simple infections could kill. How can we ensure there is a sustainable pipeline of new antimicrobials?
By Uwe Schoenbeck, PhD, SVP & chief scientific officer, Emerging Science & Innovation, Pfizer
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.